Actually, a study on colon cancer is currently trialling a combinatorial treatment of BRAF/MEK and EGFR with Dabrafenib, Trametinib and Panitumumab (www.clinicaltrials.gov, ID:NCT01750918). The gene discussed is EGFR; the disease is malignant colon neoplasm.